p. 1549 - 1551
(2007)p. 14075 - 14079
(2020)(2021/09/20)
(2021/01/29)
(2021/01/29)
p. 1899 - 1902
(2020/03/03)(2019/03/08)
p. 3986 - 3990
(2019/07/31)p. 3238 - 3242
(2018/04/24)p. 6820 - 6825
(2016/08/16)p. 965 - 984
(2016/02/23)p. 5629 - 5632
(2016/12/14)(2016/05/19)
p. 2960 - 2963
(2015/06/30)p. 262 - 267
(2013/10/01)p. 6776 - 6778
(2015/01/09)p. 2220 - 2225
(2013/03/13)p. 4666 - 4670
(2012/06/30)p. 11307 - 11309,3
(2020/10/15)p. 300 - 305
(2012/01/05)p. 471 - 474
(2012/03/08)p. 648 - 654
(2012/01/06)p. 8294 - 8298
(2011/08/21)p. 6900 - 6901
(2010/07/05)p. 3567 - 3569
(2010/10/02)p. 1253 - 1255
(2008/03/28)p. 1201 - 1209
(2008/02/01)(2008/06/13)
triethyl orthoformate
4-chlorobenzoic acid hydrazide
sodium chlorodifluoroacetate
1-Chloro-4-iodobenzene
N,N-dimethyl-formamide
2-(4-chlorophenyl)-5-[(4-methylphenyl)ethynyl]-1,3,4-oxadiazole
4-[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]morpholine
2-(benzo[d]thiazol-2-yl)-5-(4-chlorophenyl)-1,3,4-oxadiazole
2-(4-chlorophenyl)-5-(naphthalen-1-yl)-1,3,4-oxadiazole
2-(4-chlorophenyl)-5-(4-fluorophenyl)-1,3,4-oxadiazole